a murine transitional cell carcinoma tumor model has been used to evaluate the combined use of radiotherapy and three chemotherapeutic agents , doxorubicin hydrochloride ( adriamycin ) , cyclophosphamide , and cis-diamminedichloroplatinum .
C0546861
doxorubicin
C0085752
adriamycin